Publications

• 
  
• Aging, graying and loss of melanocyte stem cells
  Sarin, K. Y., & Artandi, S. E. (2007). Aging, graying and loss of melanocyte stem cells. STEM CELL REVIEWS, 3(3), 212–217.
• TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program
  Choi, J., Southworth, L. K., Sarin, K. Y., Venteicher, A. S., Ma, W., Chang, W., … Artandi, S. E. (2008). TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLOS GENETICS, 4(1).
• Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Shkreli, M., Sarin, K. Y., Pech, M. F., Papeta, N., Chang, W., Brockman, S. A., … Artandi, S. E. (2012). Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nature Medicine, 18(1), 111–119.
  
• Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab Sarin, K. Y., & Fiorentino, D. (2012). Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab. ARCHIVES OF DERMATOLOGY, 148(9), 990–992.
  
• 
  
• 
  
• 
  
• Dermatomyositis associated with capecitabine in the setting of malignancy Chen, F. W., Zhou, X., Egbert, B. M., Swetter, S. M., & Sarin, K. Y. (2014). Dermatomyositis associated with capecitabine in the setting of malignancy. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(2), E47–E48.
  
• 
  
• Genomic analysis of smoothened inhibitor resistance in Basal cell carcinoma. Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., Januario, T., … de Sauvage, F. J. (2015). Genomic analysis of smoothened inhibitor resistance in Basal cell carcinoma. Cancer Cell, 27(3), 327–341.
  
• Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma. Atwood, S. X., Sarin, K. Y., Li, J. R., Yao, C. Y., Urman, N. M., Chang, A. L. S., … Oro, A. E. (2015). Rolling the Genetic Dice: Neutral and Deleterious Smoothened Mutations in Drug-Resistant Basal Cell Carcinoma. Journal of Investigative Dermatology, 135(8), 2138–2141.
  
• Dermatologic applications of direct-to-consumer genomic analysis. Fogel, A. L., Azizi, N., Tang, J., & Sarin, K. Y. (2014). Dermatologic applications of direct-to-consumer genomic analysis. Journal of the American Academy of Dermatology, 71(5), 993–995.
  
• A subdermal source: contact dermatitis. Fogel, A. L., Longmire, M., Rieger, K. E., & Sarin, K. Y. (2015). A subdermal source: contact dermatitis. American Journal of Medicine, 128(6), 578–581.
  
• Molecular Profiling to Diagnose a Case of Atypical Dermatomyocitis Sarin, K., Chung, L., Kim, J., Higgs, B. W., Jallal, B., Yao, Y., & Fiorentino, D. (2013). Molecular Profiling to Diagnose a Case of Atypical Dermatomyocitis. Journal of Investigative Dermatology, 133(12).
  
• 
  
• Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma. Ransohoff, K. J., Sarin, K. Y., & Tang, J. Y. (2015). Smoothened Inhibitors in Sonic Hedgehog Subgroup Medulloblastoma. Journal of Clinical Oncology , 33(24), 2692–2694.
  
• 
  
• Squamous Change in Basal-Cell Carcinoma with Drug Resistance Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (2015). Squamous Change in Basal-Cell Carcinoma with Drug Resistance. NEW ENGLAND JOURNAL OF MEDICINE, 373(11), 1079–1082.
  
• Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors Sarin, K. Y., Tang, J. Y., Ransohoff, K. J., & Jaju, P. D. (2016). Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors. Journal of The American Academy of Dermatology, 74(3).
  
• Familial skin cancer syndromes: Increased melanoma risk Jaju, P. D., Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (2016). Familial skin cancer syndromes: Increased melanoma risk. Journal of The American Academy of Dermatology, 74(3).
  
• Effects of combined treatment with arsenic trioxide and itraconazole in patients with refractory metastatic basal cell carcinoma Sarin, K. Y., Ally, M. S., Ransohoff, K. J., Atwood, S. X., & Rezaee, M. (2016). Effects of combined treatment with arsenic trioxide and itraconazole in patients with refractory metastatic basal cell carcinoma. JAMA Dermatology.
  
• An investigator-initiated open label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib Sarin, K. Y., Oro, A. E., Chang, A. L., & Danial, C. (2015). An investigator-initiated open label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research.
  
• A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities, and controversy Fogel, A. L., & Sarin, K. Y. (2016). A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities, and controversy. Journal of Telemedicine and Telecare, (January).
  
• The digital age of melanoma management: detection and diagnostics Fogel, A. L., & Sarin, K. Y. (2015). The digital age of melanoma management: detection and diagnostics. Future Medicine, 2(4).
  
• Familial skin cancer syndromes Increased melanoma risk Ransohoff, K. J., Jaju, P. D., Tang, J. Y., Carbone, M., Leachman, S., & Sarin, K. Y. (2016). Familial skin cancer syndromes Increased melanoma risk. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(3), 423–434.
  
• Familial skin cancer syndromes Increased risk of nonmelanotic skin cancers and extracutaneous tumors Jaju, P. D., Ransohoff, K. J., Tang, J. Y., & Sarin, K. Y. (2016). Familial skin cancer syndromes Increased risk of nonmelanotic skin cancers and extracutaneous tumors. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(3), 437–451.
  
• 
  
• Assessment of Accuracy of Patient-Initiated Differential Diagnosis Generation by Google Reverse Image Searching. Ransohoff, J. D., Li, S., & Sarin, K. Y. (2016). Assessment of Accuracy of Patient-Initiated Differential Diagnosis Generation by Google Reverse Image Searching. JAMA Dermatology, 152(10), 1164–1166.
  
• 
  
• 
  
• 
  
• 
  
• Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma. Jaju, P., Novoa, R. A., Swetter, S. M., & Sarin, K. Y. (2016). Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma. Pediatric Dermatology.
  
• Direct-to-consumer teledermatology services for pediatric patients: Room for improvement. Fogel, A. L., Teng, J., & Sarin, K. Y. (2016). Direct-to-consumer teledermatology services for pediatric patients: Room for improvement. Journal of the American Academy of Dermatology, 75(5), 887–888.
  
• Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions Urman, N. M., Mirza, A., Atwood, S. X., Whitson, R. J., Sarin, K. Y., Tang, J. Y., & Oro, A. E. (2016). Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions. PLOS ONE, 11(12).
  
• 
  
• Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. Chahal, H. S., Rieger, K. E., & Sarin, K. Y. (2017). Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. Journal of the American Academy of Dermatology, 76(2), 353–54.
  
• 
  
• A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities and controversy. Fogel, A. L., & Sarin, K. Y. (2017). A survey of direct-to-consumer teledermatology services available to US patients: Explosive growth, opportunities and controversy. Journal of Telemedicine and Telecare, 23(1), 19–25.
  
• 
  
• Basosquamous Carcinoma: Controversy, Advances, and Future Directions. Tan, C. Z., Rieger, K. E., & Sarin, K. Y. (2017). Basosquamous Carcinoma: Controversy, Advances, and Future Directions. Dermatologic Surgery , 43(1), 23–31.
  
• Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma Jaju, P., Novoa, R. A., Swetter, S. M., & Sarin, K. Y. (2017). Invasive Melanoma in a Patient with Congenital Ichthyosiform Erythroderma. PEDIATRIC DERMATOLOGY, 34(1), E35–E36.
  
• Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma. Lin, Y., Chahal, H. S., Wu, W., Cho, H. G., Ransohoff, K. J., Song, F., … Han, J. (2017). Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma. International Journal of Cancer.
  
• Genetic diseases associated with an increased risk of skin cancer development in childhood. Fogel, A. L., Sarin, K. Y., & Teng, J. M. C. (2017). Genetic diseases associated with an increased risk of skin cancer development in childhood. Current Opinion in Pediatrics.
  
• 
  
• 
  
• IFN?-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment. Nirschl, C. J., Suárez-Fariñas, M., Izar, B., Prakadan, S., Dannenfelser, R., Tirosh, I., … Anandasabapathy, N. (2017). IFN?-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment. Cell, 170(1), 127–41.e15.
  
• Genomic Stability in Syndromic Basal Cell Carcinoma. Chiang, A., Jaju, P. D., Batra, P., Rezaee, M., Epstein, E. H., Tang, J. Y., & Sarin, K. Y. (2017). Genomic Stability in Syndromic Basal Cell Carcinoma. The Journal of Investigative Dermatology.
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
•